Research Institute of Medical Sciences, Chonnam National University Medical School, Gwangju 501-190, Korea.
Int J Mol Sci. 2020 May 12;21(10):3420. doi: 10.3390/ijms21103420.
Matrix metalloproteinase-9 (MMP-9) plays a crucial role in cell invasion and cancer metastasis. In this study, we showed that cholic acid (CA), a major primary bile acid, can induce MMP-9 expression in colon cancer HT29 and SW620 cells. CA increased reactive oxygen species (ROS) production and also activated phosphorylation of ERK1/2, JNK, and p38 MAPK. Specific inhibitors and mutagenesis studies showed that ERK1/2 and JNK functioned as upstream signals in the activation of AP-1, and p38 MAPK functioned as an upstream signal in the activation of NF-κB. N-acetyl-L-cysteine (NAC, an ROS scavenger) and diphenyleneiodonium chloride (DPI, an NADPH oxidase inhibitor) inhibited CA-induced activation of ERK1/2, JNK, and p38 MAPK, indicating that ROS production by NADPH oxidase could be the furthest upstream signal in MMP-9 expression. Colon cancer cells pretreated with CA showed remarkably enhanced invasiveness. Such enhancement was partially abrogated by MMP-9-neutralizing antibodies. These results demonstrate that CA could induce MMP-9 expression via ROS-dependent ERK1/2, JNK-activated AP-1, and p38-MAPK-activated NF-κB signaling pathways, which in turn stimulate cell invasion in human colon cancer cells.
基质金属蛋白酶-9(MMP-9)在细胞侵袭和癌症转移中起着关键作用。在这项研究中,我们表明胆酸(CA),一种主要的初级胆汁酸,可以诱导结肠癌 HT29 和 SW620 细胞中 MMP-9 的表达。CA 增加了活性氧(ROS)的产生,还激活了 ERK1/2、JNK 和 p38 MAPK 的磷酸化。特异性抑制剂和诱变研究表明,ERK1/2 和 JNK 作为 AP-1 激活的上游信号,p38 MAPK 作为 NF-κB 激活的上游信号。N-乙酰-L-半胱氨酸(NAC,一种 ROS 清除剂)和二苯碘(DPI,一种 NADPH 氧化酶抑制剂)抑制 CA 诱导的 ERK1/2、JNK 和 p38 MAPK 的激活,表明 NADPH 氧化酶产生的 ROS 可能是 MMP-9 表达的最上游信号。用 CA 预处理的结肠癌细胞表现出明显增强的侵袭性。这种增强作用部分被 MMP-9 中和抗体所阻断。这些结果表明,CA 可以通过 ROS 依赖性 ERK1/2、JNK 激活的 AP-1 和 p38-MAPK 激活的 NF-κB 信号通路诱导 MMP-9 的表达,从而刺激人结肠癌细胞的侵袭。
Toxicol Appl Pharmacol. 2013-8-24
Am J Physiol Heart Circ Physiol. 2007-12
Front Mol Biosci. 2024-11-27
BMC Cancer. 2023-11-14
Cancer Cell Int. 2018-5-21
Nat Rev Gastroenterol Hepatol. 2017-10-11
Int J Cancer. 2017-6-1
Stem Cell Res Ther. 2016-12-1
Pharmacol Rev. 2014-10